The acquired portfolio includes Sporlac which is the third largest probiotics brand in India and specialized products such as Lobun – a probiotic used for delaying progression of Chronic Kidney Disease and Oxalo – an alternate risk-free therapy to decalcify kidney stones. The reproductive health segment has a complete range of infertility and hormone products.